Enregistré dans:
| Auteurs principaux: | Lorenzo Storino Ramacciotti, Masatomo Kaneko, Severin Rodler, Muneeb Mohideen, Jie Cai, Gangning Liang, Manju Aron, Michelle Hopstone, Mariana C. Stern, Giovanni E. Cacciamani, Inderbir Gill, Andre Luis Abreu |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.447 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
par: Thomas Philip Cahill, et autres
Publié: (2024)
par: Thomas Philip Cahill, et autres
Publié: (2024)
Computerized tomography‐derived body composition metrics are associated with 24‐h urine lithogenic parameters
par: Reza Lahiji, et autres
Publié: (2026)
par: Reza Lahiji, et autres
Publié: (2026)
Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
par: Joshua Yi Min Tung, et autres
Publié: (2026)
par: Joshua Yi Min Tung, et autres
Publié: (2026)
Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
par: Maxwell Louis Sandberg, et autres
Publié: (2026)
par: Maxwell Louis Sandberg, et autres
Publié: (2026)
Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
par: Eric Margolis, et autres
Publié: (2025)
par: Eric Margolis, et autres
Publié: (2025)
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
par: Esther H. J. Hamoen, et autres
Publié: (2025)
par: Esther H. J. Hamoen, et autres
Publié: (2025)
The carbon footprint of transperineal prostate biopsy
par: Daniel A. Carson, et autres
Publié: (2025)
par: Daniel A. Carson, et autres
Publié: (2025)
Emerging tools for the early detection of prostate cancer
par: Muhammad Haider, et autres
Publié: (2025)
par: Muhammad Haider, et autres
Publié: (2025)
Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
par: Sophia M. Abusamra, et autres
Publié: (2025)
par: Sophia M. Abusamra, et autres
Publié: (2025)
Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
par: Abel Tesfai, et autres
Publié: (2024)
par: Abel Tesfai, et autres
Publié: (2024)
Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
par: Ansh Bhatia, et autres
Publié: (2024)
par: Ansh Bhatia, et autres
Publié: (2024)
Bibliometric analysis of focal therapy in prostate cancer research
par: Mohammed Shahait, et autres
Publié: (2024)
par: Mohammed Shahait, et autres
Publié: (2024)
‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
par: Ryan Sutherland, et autres
Publié: (2024)
par: Ryan Sutherland, et autres
Publié: (2024)
Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
par: Ailene E. Corona, et autres
Publié: (2026)
par: Ailene E. Corona, et autres
Publié: (2026)
The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
par: André B. Silva, et autres
Publié: (2026)
par: André B. Silva, et autres
Publié: (2026)
Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
par: Mathew Thakur, et autres
Publié: (2024)
par: Mathew Thakur, et autres
Publié: (2024)
Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
par: Eric V. Li, et autres
Publié: (2024)
par: Eric V. Li, et autres
Publié: (2024)
National survey of urologists' views on prostate cancer screening in the United Kingdom
par: Nikhil Mayor, et autres
Publié: (2026)
par: Nikhil Mayor, et autres
Publié: (2026)
Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
par: Nadia Rokan, et autres
Publié: (2025)
par: Nadia Rokan, et autres
Publié: (2025)
Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
par: Emilien Seizilles de Mazancourt, et autres
Publié: (2025)
par: Emilien Seizilles de Mazancourt, et autres
Publié: (2025)
Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
par: Ruth Pidsley, et autres
Publié: (2024)
par: Ruth Pidsley, et autres
Publié: (2024)
WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
par: Mohamad Baker Berjaoui, et autres
Publié: (2024)
par: Mohamad Baker Berjaoui, et autres
Publié: (2024)
The significant costs of prostate cancer management—An analysis from a Caribbean hospital
par: Geneva Pantoja, et autres
Publié: (2025)
par: Geneva Pantoja, et autres
Publié: (2025)
Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
par: Sofia Mesquita, et autres
Publié: (2025)
par: Sofia Mesquita, et autres
Publié: (2025)
Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
par: Lu Yu Kuo, et autres
Publié: (2025)
par: Lu Yu Kuo, et autres
Publié: (2025)
Risk factors of negative prostate biopsies: A CHAID decision tree analysis
par: Pierre Allainguillaume, et autres
Publié: (2026)
par: Pierre Allainguillaume, et autres
Publié: (2026)
Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
par: Jeremy Cheng, et autres
Publié: (2025)
par: Jeremy Cheng, et autres
Publié: (2025)
Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
par: Samantha Shekar, et autres
Publié: (2025)
par: Samantha Shekar, et autres
Publié: (2025)
Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
par: Jonathon Dawson, et autres
Publié: (2024)
par: Jonathon Dawson, et autres
Publié: (2024)
A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
par: Marcus Sondermann, et autres
Publié: (2025)
par: Marcus Sondermann, et autres
Publié: (2025)
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
par: Arjun Pon Avudaiappan, et autres
Publié: (2024)
par: Arjun Pon Avudaiappan, et autres
Publié: (2024)
Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
par: Muhammad Haider, et autres
Publié: (2025)
par: Muhammad Haider, et autres
Publié: (2025)
AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
par: Muhammad Imran, et autres
Publié: (2026)
par: Muhammad Imran, et autres
Publié: (2026)
Potential gains from radical treatment of men with prostate cancer according to life expectancy
par: Sandra Irenaeus, et autres
Publié: (2025)
par: Sandra Irenaeus, et autres
Publié: (2025)
Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
par: Alan Priester, et autres
Publié: (2024)
par: Alan Priester, et autres
Publié: (2024)
Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
par: Austin Drysch, et autres
Publié: (2025)
par: Austin Drysch, et autres
Publié: (2025)
Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
par: Sean Lim, et autres
Publié: (2024)
par: Sean Lim, et autres
Publié: (2024)
Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
par: Jennifer Dunsmore, et autres
Publié: (2024)
par: Jennifer Dunsmore, et autres
Publié: (2024)
MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
par: Herbert Lepor, et autres
Publié: (2025)
par: Herbert Lepor, et autres
Publié: (2025)
AI‐driven preoperative risk assessment in kidney cancer surgery: A comparative feasibility study of machine learning models
par: Julia Mühlbauer, et autres
Publié: (2025)
par: Julia Mühlbauer, et autres
Publié: (2025)
Documents similaires
-
Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
par: Thomas Philip Cahill, et autres
Publié: (2024) -
Computerized tomography‐derived body composition metrics are associated with 24‐h urine lithogenic parameters
par: Reza Lahiji, et autres
Publié: (2026) -
Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
par: Joshua Yi Min Tung, et autres
Publié: (2026) -
Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
par: Maxwell Louis Sandberg, et autres
Publié: (2026) -
Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
par: Eric Margolis, et autres
Publié: (2025)